Kamada Ltd - ESG Rating & Company Profile powered by AI
The webpage includes a questions and answers section for Kamada Ltd. This webpage contains a zero-cost ESG analysis for Kamada Ltd. Alternative companies in the scoring industry group for Kamada Ltd are shownin the table.
Kamada Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Kamada Ltd | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Kamada Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Kamada Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Kamada Ltd report the average age of the workforce?
Sign up for free to unlockDoes Kamada Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Kamada Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Kamada Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Kamada Ltd offer flexible work?
Sign up for free to unlockDoes Kamada Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Kamada Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Kamada Ltd conduct supply chain audits?
Sign up for free to unlockDoes Kamada Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Kamada Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Kamada Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Kamada Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Kamada Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Kamada Ltd disclose water use targets?
Sign up for free to unlockDoes Kamada Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Kamada Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Kamada Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Kamada Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Kamada Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Kamada Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Kamada Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Kamada Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Kamada Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Kamada Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Kamada Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Kamada Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Kamada Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Kamada Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Kamada Ltd disclose its waste policy?
Sign up for free to unlockDoes Kamada Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Kamada Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Kamada Ltd disclose energy use targets?
Sign up for free to unlockDoes Kamada Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Kamada Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Kamada Ltd
These potential risks are based on the size, segment and geographies of the company.
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates in two segments, Proprietary Products and Distribution. The company offers Glassia for use in chronic augmentation and maintenance therapy in adults with emphysema due to congenital Alpha-1 Antitrypsin (AAT) deficiency. It also provides KamRAB for prophylaxis of rabies disease; KamRho (D) IM to treat prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes Bramitob to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; IVIG 5% for the treatment of various immunodeficiency-related conditions; AeroBika, an OPEP device; Varitect, a varicella zoster immunoglobulin; Zutectra and Hepatect CP for the prevention of hepatitis B virus; Megalotect, a CMV immunoglobulin; and RUCONEST for the treatment of acute angioedema attacks in adults with hereditary angioedema. Further, it distributes Heparin sodium injection to treat thrombo-embolic disorders; Albumin and Albumin 4% for maintenance of blood plasma; and coagulation factors comprising Factor VIII and Factor IX, as well as IXIARO vaccine. It markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceutical Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.